ROTH DAVID (Chief Medical Officer) exercised options at SYROS PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 11/4/2024ACC: 0000950170-24-120872
Officer· Chief Medical Officer
Since Feb 2019
-6.78K
Net shares
Net seller
$14.2K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
18.88K acquired · 25.65K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+18.88K
Price / share
—
Trade value
—
% of position
New position
10/31/2024
0.00→18.88K
Common Stock
Direct
Shares
−6.78K
Price / share
$2.09
Trade value
$14.16K
% of position
35.9%
10/31/2024
18.88K→12.10K
Total
Net shares
+12.10K
Net value
-$14.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/31/2024 | M · Option Exercise | +18.88K | — | — | New position | 0.00 | 18.88K |
| Common Stock Direct | 10/31/2024 | F · Tax Withholding | −6.78K | $2.09 | $14.16K | 35.9% | 18.88K | 12.10K |
| Total | +12.10K | -$14.16K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
18.88K shares
Shares
−18.88K
Strike price
Held after
0.00
Exercisable
—
10/31/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock18.88K shares | 10/31/2024 | M · Option Exercise | −18.88K | — | 0.00 |